Issue StoriesManaging Menopause and Sleepby Neha H. Badheka, MD; Mohamed T. Sameen, MD, DABSM; and Russell Rozensky, RRT, CPFT, RPSGT Properly identifying and managing sleep disturbances during menopause can improve womens overall quality of life.
This story is probably told by 5,000 women who enter menopause every day in the United States. This case highlights a common complaint encountered during menopause and its transition. It is no surprise considering that the prevalence of sleep disturbances increases by 50% to 100% for perimenopausal and postmenopausal women compared with premenopausal women.1 Menopause is a natural part of the aging process. According to the World Health Organization, menopause is defined as the permanent cessation of menstrual periods that occurs naturally. Natural menopause is recognized after 12 consecutive months without menstrual periods that are not associated with a physiologic (lactation) or pathologic cause. In the United States, most women experience menopause between 40 and 58 years of age, with a median age of 52.2 Menopause heralds a constellation of distressing symptoms, which play havoc with the body. The symptoms linked to menopause are: sleep disturbances, hot flashes, night sweats, and vaginal dryness. In addition, a woman may have painful intercourse, mood and cognitive problems, somatic symptoms, urinary incontinence, and bleeding problems.2 In this article, we have briefly outlined common causes of sleep disturbance and its management in perimenopausal women. Sleep and Menopause Generally, postmenopausal women are less satisfied with their sleep and as many as 61% report insomnia symptoms.4 The National Sleep Foundation has reported that 20% of menopausal and postmenopausal women sleep less than 6 hours per night during the workweek, while only 12% of premenopausal women (with the exception of pregnant women) sleep less than 6 hours.5 Snoring has also been found to be more common and severe in postmenopausal women. The prevalence of clinically defined sleep apneaapnea/hypopnea index >10 plus the presence of daytime symptoms including daytime sleepiness, hypertension, or some other cardiovascular symptomfor premenopausal women was 0.6% compared to 1.9% for postmenopausal women.6 Data on self-reported symptoms in older women reveal the following problems:
Impaired sleep can lead to difficulty concentrating at work, memory problems, anxiety, and overall poor quality of life. There are important implications for mood, behavior, and cognitive performance. Possible Etiologies Of Sleep Disturbance SDB and Snoring: These may be at least partially due to metabolic/hormonal factors. Studies7 have examined the role of progestational hormones in sleep apnea. The level of awake genioglossus EMG is higher in the luteal phase, followed by the follicular phase, and is lowest in postmenopausal women. Progesterone levels fall after menopause, and progestogens have been shown to stimulate ventilation during the luteal phase. Thus, these patients may have decreased ventilatory drive and hypotonia in pharyngeal muscles due to low levels of progesterone. This can further deteriorate during deep stages of sleep resulting in apneic symptoms. Increased Obesity: Whether this is a specific menopausal effect or simply reflects aging is unclear7; however, this increasing central obesity may explain the association between menopause and the prevalence of sleep apnea. Nocturia: This is another problem that can cause multiple nighttime awakenings as well as cause the quality of sleep to suffer. This could be an age-related problem vs menopause. Lin et al8 have demonstrated that occurrence of nocturia was significantly higher in the elderly age group. Depression: Insomnia seen in menopausal women may well be due to concurrent psychopathology, with the most common being depression. The single strongest risk factor of chronic insomnia is depression followed by female gender. Kloss et al9 have shown that self-report ratings of depressive symptoms, trait anxiety, hot flashes, and dysfunctional beliefs and attitudes about sleep significantly correlated with poor sleep quality. It may also be possible that the primary sleep disturbance gives rise to depression. This highlights the interplay between physiological and psychological mechanisms among perimenopausal women. RLS and PLMD: The prevalence of these disorders increases with age and can be contributory to the sleep problems in middle-aged women. Thus, the sleep disturbances experienced by women around menopause are multifactorial in origin and are best managed using a multidisciplinary approach. Treatment Options Pharmacotherapy Tibolone: This synthetic steroid compound with relatively weak hormonal activity is effective for hot flashes and sleep disturbances; however, the drug is not available in the United States. It has been used in Europe for almost 20 years.2 Antidepressants: Examples such as paroxetine and venlafaxine may decrease hot flashes to a moderate degree in symptomatic women.2 Gabapentin: This drug demonstrates a benefit in hot flash frequency and sleep in one study. More studies are needed to replicate the result.2 Alternative Therapy Exercise Treatment of OSA Other Treatment Suggestions Short-term treatment with nonbenzodiazepine agents like zolpidem or zaleplon can be sometimes considered to break the cycle of insomnia while the above therapies are initiated. Undiagnosed sleep disturbances may contribute to fatigue and muscle aches, cognitive dysfunction, anxiety, and depression. Patients may attribute their sleep problems to normal changes in menopause and, hence, may not report them until specifically asked. National Institutes of Health-sponsored studies are under way (Study of Womens Health Across the Nation),10 which will enhance our understanding of sleep difficulties in middle-aged women. Recognition, proper identification, and effective management of sleep disturbances during menopause can go a long way in improving overall quality of life in this population. Neha H. Badheka, MD, is an extern; Mohamed T. Sameen, MD, DABSM, is medical director; and Russell Rozensky, RRT, CPFT, RPSGT, is supervisor at the John T. Mather Memorial Hospital Sleep Apnea Center, Port Jefferson, NY. References |
|
|
|
ADDITIONAL ONLINE RESOURCES |
|